The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Propyl-5,6,6a,7,8,12b-hexahydro-benzo[a]phenanthridine-10,11-diol ID: ALA299161
PubChem CID: 9904738
Max Phase: Preclinical
Molecular Formula: C20H23NO2
Molecular Weight: 309.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCN1Cc2ccccc2[C@@H]2c3cc(O)c(O)cc3CC[C@H]21
Standard InChI: InChI=1S/C20H23NO2/c1-2-9-21-12-14-5-3-4-6-15(14)20-16-11-19(23)18(22)10-13(16)7-8-17(20)21/h3-6,10-11,17,20,22-23H,2,7-9,12H2,1H3/t17-,20-/m1/s1
Standard InChI Key: VNVHTKVGILYCGH-YLJYHZDGSA-N
Molfile:
RDKit 2D
25 28 0 0 1 0 0 0 0 0999 V2000
2.1167 -3.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8792 -3.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -3.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6417 -3.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8875 -2.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -4.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3542 -3.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -1.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 -2.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -3.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3542 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -4.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 -4.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8792 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -3.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1708 -3.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1750 -4.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6667 -0.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1625 -4.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -0.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9042 -0.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9250 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -2.7292 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -4.0667 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 1 0
4 2 1 0
5 2 1 0
6 1 1 0
7 1 2 0
8 5 2 0
9 8 1 0
10 7 1 0
11 6 2 0
12 10 2 0
13 14 1 0
14 6 1 0
15 3 1 0
16 10 1 0
17 12 1 0
18 5 1 0
19 8 1 0
20 15 1 0
21 18 2 0
22 21 1 0
23 20 1 0
2 24 1 6
4 25 1 1
12 11 1 0
4 13 1 0
9 3 1 0
22 19 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.41Molecular Weight (Monoisotopic): 309.1729AlogP: 3.77#Rotatable Bonds: 2Polar Surface Area: 43.70Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.55CX Basic pKa: 8.22CX LogP: 4.08CX LogD: 3.36Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.83Np Likeness Score: 0.54
References 1. Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB.. (1990) trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist., 33 (6): [PMID:1971308 ] [10.1021/jm00168a034 ] 2. Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB.. (1996) Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping., 39 (1): [PMID:8568818 ] [10.1021/jm9502100 ] 3. Knoerzer TA, Watts VJ, Nichols DE, Mailman RB.. (1995) Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors., 38 (16): [PMID:7636869 ] [10.1021/jm00016a009 ]